ALNYLAM PHARMACEUTICALS, INC.'s Net Worth
$18.6 Million
Who is ALNYLAM PHARMACEUTICALS, INC.?
ALNYLAM PHARMACEUTICALS, INC. has an estimated net worth of $18.6 Million. This is based on reported shares in Regulus Therapeutics Inc..
SEC CIK
ALNYLAM PHARMACEUTICALS, INC.'s CIK is 0001178670
Past Insider Trading and Trends
2012 was ALNYLAM PHARMACEUTICALS, INC.'s most active year for acquiring shares with 1 total transactions. ALNYLAM PHARMACEUTICALS, INC.'s most active month to acquire stocks was the month of September. 2014 was ALNYLAM PHARMACEUTICALS, INC.'s most active year for disposing of shares, totalling 65 transactions. ALNYLAM PHARMACEUTICALS, INC.'s most active month to dispose stocks was the month of September. 2012 saw ALNYLAM PHARMACEUTICALS, INC. paying a total of $0.00 for 6,150,500 shares, this is the most they've acquired in one year. In 2016 ALNYLAM PHARMACEUTICALS, INC. cashed out on 1,000,000 shares for a total of $7,180,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Regulus Therapeutics Inc. (RGLS) Snapshot price: $1.48
InvestorALNYLAM PHARMACEUTICALS, INC. owns 4,896,716 units of Common Stock which is worth $7,247,139.68. In the year 2012 ALNYLAM PHARMACEUTICALS, INC. filed a total of 22 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -16.96% | -1.00M |
$7.18 | -$7,180,000.00 | 4.9M |
Feb 23
| |||
Form 4/A
| -1.88% | -113.08K |
$14.02 | -$1,585,447.12 | 5.9M |
Scheduled
|
Oct 22 - Oct 24
| ||
Form 4
| -1.88% | -113.08K |
$14.02 | -$1,585,437.34 | 5.9M |
Scheduled
|
Oct 22 - Oct 24
| ||
Form 4
| -0.20% | -12.10K |
$6.74 | -$81,508.32 | 6.01M |
Scheduled
|
Oct 15 - Oct 17
| ||
Form 4
| -0.17% | -10.05K |
$6.56 | -$65,938.08 | 6.02M |
Scheduled
|
Oct 8 - Oct 10
| ||
Form 4
| -0.17% | -10.30K |
$6.74 | -$69,398.93 | 6.03M |
Scheduled
|
Oct 1 - Oct 3
| ||
Form 4
| -0.14% | -8.75K |
$7.13 | -$62,366.50 | 6.04M |
Scheduled
|
Sep 24 - Sep 26
| ||
Form 4
| -0.13% | -7.70K |
$7.31 | -$56,293.94 | 6.05M |
Scheduled
|
Sep 17 - Sep 19
| ||
Form 4
| -0.15% | -8.90K |
$7.85 | -$69,895.84 | 6.06M |
Scheduled
|
Sep 10 - Sep 12
| ||
Form 4
| -0.17% | -10.05K |
$7.07 | -$71,101.51 | 6.07M |
Scheduled
|
Sep 3 - Sep 5
| ||
Form 4
| -0.08% | -5.00K |
$7.00 | -$34,996.25 | 6.08M |
Scheduled
|
Aug 27 - Aug 29
| ||
Form 4
| -0.18% | -10.75K |
$6.89 | -$74,088.60 | 6.08M |
Scheduled
|
Aug 20 - Aug 22
| ||
Form 4
| -0.09% | -5.45K |
$7.01 | -$38,226.94 | 6.09M |
Scheduled
|
Aug 13 - Aug 15
| ||
Form 4
| -0.12% | -7.60K |
$6.87 | -$52,204.68 | 6.1M |
Scheduled
|
Aug 6 - Aug 8
| ||
Form 4
| -0.09% | -5.35K |
$6.35 | -$33,989.25 | 6.11M |
Scheduled
|
Jul 30 - Aug 1
| ||
Form 4
| -0.09% | -5.25K |
$6.75 | -$35,436.42 | 6.11M |
Scheduled
|
Jul 23 - Jul 25
| ||
Form 4
| -0.22% | -13.50K |
$6.66 | -$89,965.35 | 6.12M |
Scheduled
|
Jul 16 - Jul 18
| ||
Form 4
| -0.13% | -8.05K |
$6.73 | -$54,196.39 | 6.13M |
Scheduled
|
Jul 9 - Jul 11
| ||
Form 4
| -0.07% | -4.30K |
$8.07 | -$34,689.16 | 6.14M |
Scheduled
|
Jul 2 - Jul 3
| ||
Form 4
| -0.12% | -7.60K |
$7.88 | -$59,904.67 | 6.14M |
Scheduled
|
Jun 25 - Jun 27
| ||
Form 4
|
∞
| 6.15M |
—
|
—
| 6.15M |
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||